The FDA also notes that no safety-related information regarding DSIP has been identified, so its unknown whether it could be harmful to humans.26 Given these conclusions, we shouldnt be surprised that DSIP is not an FDA-approved peptide therapy
Intestinal Disease/Resection
Conclusions apply only to what was actually tested
Its utility toward this end was the subject of a 2020 analysis of two clinical trials on individuals with HIV in which the authors concluded, Tesamorelin was effective in increasing skeletal muscle area and density.17 Strength and muscle studies are lacking with regard to non-HIV subjects, but the theoretical efficacy is there
Such observations do not prove that 5-Amino-1MQ lacks organ-specific, long-duration, reproductive, developmental, hematological, immunological, genotoxic, or broader off-target risks
Patches might seem attractive because theyre cheaper, needle-free, and dont require a prescription, but they wont provide comparable results